
D. Lawson Allen
Celltrion’s and Hospira’s Production of Infliximab Biosimilars Does Not Infringe Remicide®-Related Patent
Biosimilars Law Bulletin ·
Federal Circuit: No Tribal Sovereign Immunity in IPRs
PTAB Law Blog ·
Another Lesson in Timing for Disclaimers in CBM Reviews
PTAB Law Blog ·
PTAB Denies Inter Partes Review of Rituxan® Patents
Biosimilars Law Bulletin ·